OpenAI talent exodus raises ‘huge red flag’ ahead of IPO
When OpenAI hired Denise Dresser from Slack to be its chief revenue officer in December, Fidji Simo, a…
AI infrastructure debt and leverage draw market scrutiny
As Nvidia partners with Wall Street firms to mobilize more than $500 billion of third-party capital for AI…
CPI inflation report July 2026: Prices rose 0.1% , annual rate 3.4%
A shopper browses fresh fruit at a grocery store in Wilmington, North Carolina, US, on Saturday, Aug. 8,…
Nvidia, Wall Street asset managers partner on $500B AI push
Nvidia is attempting to turn its artificial intelligence chips into Wall Street’s newest asset class, partnering with six…
We’re increasing our Eli Lilly price target after another beat-and-raise quarter
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
Palantir stock rises 27% on soaring commercial revenue, AI sovereignty
Palantir CEO Alex Karp speaks during an interview on July 27, 2026 in New York City. John Lamparski…
Big Tech’s Anthropic and OpenAI stakes distort corporate earnings
India Prime Minister Narendra Modi, left, with OpenAI CEO Sam Altman, center, and Anthropic CEO Dario Amodei at…
Kalshi traders think July jobs will come in cooler than estimates
A Contemporary Services Corporation (CSC) now hiring flyer is displayed for job opportunities as an event security guard…
Alibaba shares rally after unveiling Qwen3.8-Max AI model
Alibaba debuts Qwen3-Max, its trillion-parameter AI model trained on 36T tokens. (Photo by Nikolas Kokovlis/NurPhoto via Getty Images)…
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business
The boom in GLP-1 weight-loss drugs and other specialized medicines has created lucrative logistics opportunities in an industry…
Leopold Aschenbrenner Situational Awareness fund: $45B to fire sale
Leopold Aschenbrenner Photo: Josh Edelson Two years ago, Leopold Aschenbrenner argued he was one of few people in…
Novo Nordisk shares fall after heart medicine trial results
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…